| William Robert Lucas Jr, MD | |
|
4717 Saint Antoine St, Kresge Eye Institute, Detroit, MI 48201-1423 | |
| (313) 577-8900 | |
| (313) 577-0700 |
| Full Name | William Robert Lucas Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 47 Years |
| Location | 4717 Saint Antoine St, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053388074 | NPI | - | NPPES |
| 2121874-10-0 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301041442 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harper University Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physician Group | 8628087681 | 345 |
News Archive
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller, M.D., Director of the Forbes Norris MDA/ALS Research Center at Sutter Health's California Pacific Medical Center in San Francisco, has been awarded a grant from The ALS Association for $1.5 million to help fund a Phase 2 clinical study of the company's investigational therapy for ALS, NP001.
ProBioGen AG, a technology and service provider for the development and production of biopharmaceutical drug substances today announced signing a contract with Virdante Biopharmaceuticals, Inc., a US-based biopharmaceutical development company.
Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.
More than 500 mental health researchers, practitioners, and advocates representing over 40 countries will gather for the Sixth World Conference on the Promotion of Mental Health and Prevention of Mental and Behavioral Disorders, November 17–19, 2010, at the Omni Shoreham Hotel in Washington, D.C. With the theme Addressing Imbalances: Promoting Equity in Mental Health, the conference will focus on inequalities in care, research, and practice in ways that protect the most vulnerable.
› Verified 7 days ago
| Entity Name | University Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447299797 PECOS PAC ID: 8628087681 Enrollment ID: O20060419000518 |
News Archive
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller, M.D., Director of the Forbes Norris MDA/ALS Research Center at Sutter Health's California Pacific Medical Center in San Francisco, has been awarded a grant from The ALS Association for $1.5 million to help fund a Phase 2 clinical study of the company's investigational therapy for ALS, NP001.
ProBioGen AG, a technology and service provider for the development and production of biopharmaceutical drug substances today announced signing a contract with Virdante Biopharmaceuticals, Inc., a US-based biopharmaceutical development company.
Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.
More than 500 mental health researchers, practitioners, and advocates representing over 40 countries will gather for the Sixth World Conference on the Promotion of Mental Health and Prevention of Mental and Behavioral Disorders, November 17–19, 2010, at the Omni Shoreham Hotel in Washington, D.C. With the theme Addressing Imbalances: Promoting Equity in Mental Health, the conference will focus on inequalities in care, research, and practice in ways that protect the most vulnerable.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Robert Lucas Jr, MD 1560 E Maple Rd, Suite 400-credentialing, Troy, MI 48083-1138 Ph: (313) 577-8900 | William Robert Lucas Jr, MD 4717 Saint Antoine St, Kresge Eye Institute, Detroit, MI 48201-1423 Ph: (313) 577-8900 |
News Archive
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller, M.D., Director of the Forbes Norris MDA/ALS Research Center at Sutter Health's California Pacific Medical Center in San Francisco, has been awarded a grant from The ALS Association for $1.5 million to help fund a Phase 2 clinical study of the company's investigational therapy for ALS, NP001.
ProBioGen AG, a technology and service provider for the development and production of biopharmaceutical drug substances today announced signing a contract with Virdante Biopharmaceuticals, Inc., a US-based biopharmaceutical development company.
Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.
More than 500 mental health researchers, practitioners, and advocates representing over 40 countries will gather for the Sixth World Conference on the Promotion of Mental Health and Prevention of Mental and Behavioral Disorders, November 17–19, 2010, at the Omni Shoreham Hotel in Washington, D.C. With the theme Addressing Imbalances: Promoting Equity in Mental Health, the conference will focus on inequalities in care, research, and practice in ways that protect the most vulnerable.
› Verified 7 days ago
Dr. Murray Dale Christianson, M.D., F.R.C.S.(C), Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2799 W Grand Blvd, Henry Ford Hospital, K-10, Detroit, MI 48202 Phone: 313-916-3730 | |
Deborah A. Darnley-fisch, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 Fax: 313-916-3235 | |
Dr. Daniel Seth Zuckerbrod, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 14400 West Mcnichols, Detroit, MI 48235 Phone: 313-341-3450 Fax: 313-341-2135 | |
Robert Neil Frank, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4717 St Antoine, Kresge Eye Institute, Detroit, MI 48201 Phone: 313-577-8900 Fax: 313-577-0700 | |
Dr. Hassan Ali Tokko, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 4717 Saint Antoine St, Detroit, MI 48201 Phone: 313-577-7614 | |
Mark S Juzych, MD, MHSA Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Kresge Eye Institute, 4717 St Antoine, Detroit, MI 48201 Phone: 313-577-8900 Fax: 313-577-0700 |